Immunogenicity of an E1-deleted recombinant human adenovirus against rabies by different routes of administration

Journal of General Virology

Volumn 82, Issue 9, 2001, Pages 2191-2197

  Vos, A ^a   Neubert, A ^a   Pommerening, E ^a   Muller T ^a   Dohner L ^a   Neubert, L ^a   Hughes, K ^a  

^a Impfstoffwerk Dessau Tornau GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRALIZING ANTIBODY; RABIES VACCINE; VIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; CONTROLLED STUDY; DOG; FOX; GENE CONSTRUCT; GENE DELETION; HUMAN ADENOVIRUS; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; IMMUNOREACTIVITY; INTESTINE ENDOSCOPY; JEJUNUM; MEMBRANE; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; RABIES; SEROCONVERSION; VIRUS IMMUNITY; VIRUS RECOMBINANT;

EID: 0034852390     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-82-9-2191     Document Type: Article

References (39)

1. WHO informal consultation on reference preparations and potency tests for rabies vaccines
2. Effect of the tripartite leader on synthesis of a non-viral protein in an adenovirus 5 recombinant
3. Oral rabies vaccination of skunks and foxes with a recombinant human adenovirus vaccine
4. Prophylactic immunization of humans against rabies by intradermal inoculation of human diploid cell culture vaccine
5. Viral antibodies in coyotes from California
6. Ectodomain of coxsackievirus and adenovirus receptor genetically fused to epidermal growth factor mediates adenovirus targeting to epidermal growth factor receptor-positive cells
7. Untersuchungen zur Kristallisation von Hexonen der Adenoviren der Gruppe III
8. Oral or parenteral administration of replication-deficient adenoviruses expressing the measles virus haemagglutinin and fusion proteins: Protective immune responses in rodents
9. A serologic survey of the island fox (Urocyon littoralis) on the Channel Islands, California
10. Serological survey for diseases in free-ranging coyotes (Canis latrans) in Yellowstone National Park, Wyoming
11. Vaccination with a single dose of a recombinant porcine adenovirus expressing the classical swine fever virus gp55 (E2) gene protects pigs against classical swine fever
12. Adenoviral vectors for vaccines
13. Seroepidemiological survey of sympatric domestic and wild dogs (Lycaon pictus) in Tsumkwe District, north-eastern Namibia
14. Single inoculation of replication-defective adenovirus-vectored vaccines at birth in piglets with maternal antibodies induces high level of antibodies and protection against pseudorabies
15. Oral immunization of red foxes (Vulpes vulpes L.) in Europe - A review
16. Effect of maternal immunity on the immune response of young foxes to oral vaccination against rabies with SAD B19
17. Immunogenicity and efficacy of the oral rabies vaccine SAD B19 in foxes
18. Mucosal immunization with recombinant adenoviruses: Induction of immunity and protection of cotton rats against respiratory bovine herpesvirus type 1 infection
19. A recombinant human adenovirus vaccine against rabies
20. Update on adenovirus and its vectors
21. Expression of a human coxsackie/adenovirus receptor transgene permits adenovirus infection of primary lymphocytes
22. Ein Feldversuch zur oralen Immunisierung von Füchsen gegen die Tollwut in der Bundesrepublik Deutschland. I. Unschädlichkeit, Wirksamkeit und Stabilität der Vakzine SAD B19
23. Comparative immunogenicity and efficacy studies with oral rabies vaccine SAD P5/88 in raccoon dogs and foxes
24. A rapid reproducible test for determining rabies neutralizing antibody
25. Presence of antibodies to canine distemper virus, canine parvovirus and canine adenovirus type 1 in free-ranging Jackals (Canis adustus and Canis mesomelas) in Zimbabwe
26. Progress and setbacks in the oral immunisation of foxes against rabies in Europe
27. Survey on viral pathogens in wild red foxes (Vulpes vulpes) in Germany with emphasis on parvoviruses and analysis of a DNA sequence from a red fox parvovirus
28. Adenoviral vectors for protein expression
29. Oral vaccination of foxes against rabies with SAD B19 in Europe, 1983-1998: A review
30. Basolateral localization of fiber receptors limits adenovirus infection from the apical surface of airway epithelia
31. Oral immunization against rabies: Afterthoughts and foresight
32. The use of an E1-deleted, replication-defective adenovirus recombinant expressing the rabies virus glycoprotein for early vaccination of mice against rabies virus
33. Induction of mucosal immunity with a replication-defective adenoviral recombinant
34. A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier
35. Isolation of porcine, canine and feline IgG by affinity chromatography using protein A
36. Human adenovirus type 5 vectors expressing rabies glycoprotein
37. Lack of high affinity fiber receptor activity explains the resistance of ciliated airway epithelia to adenovirus infection